Agena Bioscience today expanded its European distributors through new relationships with KAWA.SKA in Poland and BioGen-Analytica in Russia.
“We are pleased to extend our partnerships with BioGen-Analytica and KAWA.SKA not only for their experience in the biotechnology market, but also for their ability to move Agena Bioscience into the clinical and diagnostic markets. We are excited to be working with both of these companies to help better meet the growing market demand from our Eastern European customer base,” said Edvin Munk, Agena Bioscience’s Vice President and Managing Director, Europe.
“We chose Agena Bioscience because the company and its MassARRAY System fits very well into KAWA.SKA’s product portfolio to provide a more comprehensive solution for our clinical customer base – from sample to results,” said Marian Kawczynski, President of KAWA.SKA.
KAWA.SKA in Poland serves hospitals, medical academies, the Polish Academy of Sciences institutes, molecular diagnostics facilities, biotechnology companies, and industrial plants.
... to continue reading you must be subscribed
